Clinical Trials in Tennessee

Showing 12681-12700 of 20,239 trials

Study of NK012 in Patients With Refractory Solid Tumors

NCT00542958

The purpose of this study is to determine whether NK012 is safe and effective in the treatment of refractory solid tumors

Cancer

Nippon Kayaku Co., Ltd.39 participantsStarted Mar 2007

Nashville, Tennessee, United States

COMPLETEDPhase 129 miles

A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumors

NCT02471846

This study will evaluate the safety, tolerability, and pharmacokinetics of the combination of GDC-0919 and atezolizumab in participants with locally advanced, recurrent, or metastatic incurable solid malignancy that has progressed after available standard therapy or for which standard therapy is ineffective, intolerable, or inappropriate. Participants will be enrolled in two stages, including a dose-escalation stage and an expansion stage.

Solid Tumor

Genentech, Inc.158 participantsStarted Jul 2015

Scottsdale, Arizona, United States • Santa Monica, California, United States • Aurora, Colorado, United States +15 more locations

Study of NK012 in Patients With Refractory Solid Tumors

A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumors

Find Trials by Condition in Tennessee

Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)

Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008)

Dose-ranging Study of Nemolizumab in Atopic Dermatitis

CSD190101: A Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products

Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

A Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea

MIRODERM H2H DFU Study

A Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell Disease

A Study of VentriGel in Post-MI Patients

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma

A Phase 2 Multi-Center Study of Entinostat (SNDX-275) in Patient With Relapsed or Refractory Hodgkin's Lymphoma

Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants